Brooklyn Investment Group Has $453,000 Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Brooklyn Investment Group lifted its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 9.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,115 shares of the company’s stock after purchasing an additional 93 shares during the period. Brooklyn Investment Group’s holdings in HCA Healthcare were worth $453,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of HCA. Bangor Savings Bank increased its stake in HCA Healthcare by 112.5% in the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after acquiring an additional 45 shares during the last quarter. MFA Wealth Advisors LLC bought a new stake in shares of HCA Healthcare during the second quarter worth $27,000. Unique Wealth Strategies LLC bought a new stake in shares of HCA Healthcare during the second quarter worth $28,000. GPS Wealth Strategies Group LLC grew its stake in shares of HCA Healthcare by 284.0% during the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after buying an additional 71 shares during the last quarter. Finally, Benjamin F. Edwards & Company Inc. acquired a new position in shares of HCA Healthcare during the second quarter worth $33,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on HCA. Barclays cut their price target on shares of HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating on the stock in a report on Friday, November 8th. KeyCorp cut their price target on shares of HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating on the stock in a report on Monday, October 28th. UBS Group lifted their price target on shares of HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a report on Wednesday, August 14th. Wells Fargo & Company lowered shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and dropped their target price for the company from $400.00 to $320.00 in a report on Monday. Finally, TD Cowen dropped their target price on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a report on Monday, October 28th. One research analyst has rated the stock with a sell rating, five have issued a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and an average price target of $380.29.

HCA Healthcare Trading Up 1.0 %

NYSE:HCA opened at $328.95 on Wednesday. HCA Healthcare, Inc. has a one year low of $245.84 and a one year high of $417.14. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. The firm has a 50-day moving average of $376.47 and a 200-day moving average of $358.74. The company has a market cap of $83.32 billion, a PE ratio of 14.77, a PEG ratio of 1.25 and a beta of 1.68.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be given a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a yield of 0.80%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s payout ratio is 11.85%.

Insiders Place Their Bets

In other news, SVP Phillip G. Billington sold 3,897 shares of the stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the transaction, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at $18,445,700. This represents a 6.89 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Erol R. Akdamar sold 2,900 shares of the company’s stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the sale, the insider now owns 6,843 shares in the company, valued at $2,415,579. The trade was a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 15,155 shares of company stock valued at $5,608,990. Corporate insiders own 1.70% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.